INTRODUCTION
Pulmonary complications after surgery are a leading cause of postoperative morbidity and mortality. Advances in anesthesia and surgical technique have made operative intervention possible in patients with serious underlying cardiopulmonary disease who previously would have been denied surgery. There is general agreement that thoracic and upper abdominal surgery carry the highest risk of postoperative respiratory complications. Postoperative pulmonary complications contribute significantly to overall perioperative morbidity and mortality (1) . In a study of patients undergoing elective abdominal surgery, as an example, pulmonary complications occurred significantly more often than cardiac complications and were associated with significantly longer hospital stays (2) . The National Surgical Quality Improvement Program (NSQIP) also found that postoperative pulmonary complications were the most costly of major postoperative medical complications (including cardiac, thromboembolic and infectious) and resulted in the longest length of stay (3) .
The reported frequency of postoperative pulmonary complications in the literature varies from 2-70%. This wide range is due in part to patient selection and procedure-related risk factors, although differing definitions for postoperative complications account for much of the variability and make comparison of reported incidences across different studies difficult. One broad definition of postoperative pulmonary complications includes all patients with fever and either pulmonary signs or symptoms (e.g., productive cough, rhonchi or diminished breath sounds) or changes on chest Xray (e.g., atelectasis, consolidation or incomplete expansion) (4, 5) .
Chronic obstructive pulmonary disease (COPD) is a well-known independent risk factor for the development of postoperative complications after thoracic or non-thoracic surgery (6) (7) (8) . Although there is no incremental risk with an increasing severity of airflow limitation in patients undergoing noncardiothoracic surgery, such an association has been found in patients undergoing thoracic surgery (8) . As the impact of pulmonary complications following surgery has become increasingly apparent, estimation of their risk should be a standard element of all preoperative medical evaluations.
We aimed to determine the effect(s) of obstructive airways disease on complication rates following abdominal operations. The definition of postoperative pulmonary complications, identification of patient-and procedure-related risk factors and the role of preoperative pulmonary function testing will be reviewed herein.
MATERIALS AND METHODS
The study site was Zonguldak Karaelmas Universty Medical School. Thirty-two patients diagnosed with COPD out of 89 patients who underwent abdominal surgery at Zonguldak Karaelmas University Medical School Hospital were enrolled in the study. Three (9%) patients with severe COPD, 19 (60%) with moderate obstruction, and 10 (31%) with mild obstruction were selected. Using proposed criteria as a guide (9), the presence of airflow limitation is defined by forced expiratory volume in 1 second (FEV 1 )/forced vital capacity (FVC) <70%, and staging of disease severity is defined as follows: severe, if FEV 1 is less than 50% of predicted; moderate, if FEV 1 is from 50-79% of predicted; and mild, if FEV 1 is more than 80% of predicted. All of these patients were subjected to evaluations with detailed history, physical examination, chest X-ray, respiratory function tests, and arterial blood gases (when needed).
The American Society of Anesthesiologists (ASA) classification system (10) is based on the presence of systemic disturbances, which may be: absent (class 1), mild (class 2), moderate (class 3), severe (class 4), or almost certain to cause death (class 5). We used the ASA status recorded in the anesthesiologist's preoperative note. 
Anesthesia
All the patients were maintained with sevoflurane or desflurane following induction with propofol, fentanyl and midazolam. In five patients with cardiac morbidity, etomidate was used for induction instead of propofol.
Postoperative Pulmonary Complications
Data concerning postoperative pulmonary complications were obtained from the medical records by a trained research fellow. Complications were defined as follows: pulmonary infection (2 patients) documented on chest radiograph associated with a temperature of >38.5°C and/or the use of antibiotic treatment, prolonged mechanical ventilation (3 patients) due to respiratory failure, and refractory hypoxemia and unexpected postoperative use of aerosol treatment (2 patients).
Cardiac Complications
Complications were defined as follows: supraventricular tachycardia (SVT) (5 patients), ventricular arrhythmia (2 patients) and congestive heart failure (2 patients). Pulmonary (p=0.000) and cardiac (p=0.000) complication ratios were higher in the COPD patients compared with the patients without COPD (Table  2) . Postoperative pulmonary and cardiac complications were documented in 21.8% and 28.1% of our patients with COPD, respectively, who underwent abdominal surgery. There were no differences in terms of complications according to the severity of the disease in patients with COPD (p>0.05) (Table 3). While no differences were determined in terms of postoperative pulmonary and cardiac complications regarding age, abnormal chest X-ray, smoking history, or changes in preoperative ECG (p>0.05) in the patients with COPD, cardiac complication ratios were observed to be high in the patients using bronchodilator therapy (p=0.02). Table 3 . The distribution of postoperative complications in the patients undergoing abdominal operations according to the degree of obstructive airway disease ween type of incision and the duration of surgery in the patients (Table 4) .
Statistical Analysis
Likewise, no differences were determined in the COPD patients for anesthesia applied. Whereas high ASA seemed to increase the cardiac complication rate (Table 5 ), no differences were found with respect to the pulmonary complication rate. Pulmonary complications developed in 4/16 of ASA 2 patients, 2/11 of ASA 3 patients, and 1/5 of ASA 4 patients (p=0.262).
DISCUSSION
The major novel findings of the present study are as follows: (1) Pulmonary and cardiac complication ratios were higher in the COPD patients; (2) Postoperative pulmonary and cardiac complications were respectively documented in 21.8% and 28.1% of our patients with COPD who underwent abdominal surgery; (3) There were no differences in terms of complications according to the severity of the disease in patients with COPD; (4) Higher ASA class and bronchodilator administration were significantly associated with higher cardiac complication rates; and (5) There were no differences between the type of incision and the duration of surgery in the patients, but upper abdominal surgery caused more pulmonary complications than lower abdominal surgery, and significantly fewer complications were seen in laparoscopic procedures than in open surgical procedures.
The reported incidence of postoperative pulmonary complications in patients undergoing noncardiothoracic surgery varies widely (from 2% to 19%) (11) . Pulmonary function is altered in patients undergoing surgery. Decreased functional residual capacity, vital capacity and cough contribute to aspiration, atelectasis and pneumonia, frequent causes of operative morbidity. More recently, the definition of a 'pulmonary complication' has been restricted to those that are clinically significant, including pneumonia, respiratory failure with prolonged mechanical ventilation, bronchospasm, atelectasis, and exacerbation of underlying chronic lung disease. The preoperative risk factors associated with abdominal surgery have been addressed in a number of studies. COPD is a wellknown independent risk factor for the development of postoperative pulmonary complications after thoracic or non-thoracic surgery (7, (12) (13) . COPD also increases the risk of postoperative arrhythmias in patients undergoing surgery (13) . Our cases with COPD had higher rates of both pulmonary and cardiac complications. Hence, many of the criteria used to evaluate surgical risk are extrapolated from the results in patients with COPD (14) . Classically, a decrease in the FEV1 or the FVC below 70% is understood to suggest an increase in the risk of pulmonary complications. Nevertheless, in various studies, it has been shown that the patient's clinical situation at the time of the surgery is more important than the lung function parameters (15, 16) .
Patient-specific risk factors for pulmonary complications include COPD, smoking, age, obesity, and poor general medical status. In our study, except for COPD, only high ASA increased cardiac complications. Poor general medical status is a risk factor for pulmonary complications. It may be that ASA and age simply reflect underlying comorbidity (14) .
In our patients, severity of COPD did not affect the incidence of pulmonary complications. No studies have suggested a pulmonary function test value that would contraindicate surgery. In fact, empiric observations suggest that even patients with significant obstructive lung disease can successfully undergo anesthesia and major surgery (17) . In our patients, although the severity of the disease did not lead to a difference in complication rates, severe COPD patients suffered from serious pulmonary complications. However, type II error should be considered since the number of patients with severe COPD was small. While no differences were determined in terms of postoperative pulmonary and cardiac complications with respect to age, abnormal chest X-ray, smoking history, and changes in preoperative ECG (p>0.05) in the patients with COPD, cardiac complication ratios were seen to be high in the patients using bronchodilator therapy (p=0.02). The results of the study by Kroenke (16) were similar to our results. Perioperative bronchodilator administration was associated with a high cardiac complication rate. In patients without cardiac disease, selective β2-agonists rarely cause significant arrhythmias or myocardial ischemia; however, patients with underlying coronary artery disease or preexisting arrhythmias are at greater risk for these complications.
Procedure-specific risk factors for pulmonary complications include the surgical site, duration of surgery, type of anesthesia, and type of neuromuscular blockage. The surgical site is the most important risk factor. The complication rate is higher for surgical sites closer to the diaphragm, such as the thoracic region and the upper abdomen. Differences were determined in our patients with COPD who underwent upper versus lower abdominal surgery. In a recent study, unadjusted postoperative pulmonary complication rates for upper abdominal, lower abdominal, and any abdominal surgery from 43 studies were obtained. These were 19.7%, 7.7% and 14.2%, respectively (18) . Prolonged surgical procedures are associated with higher risk; however, in our patients, no such associations were determined. Open surgery was also associated with significantly higher rates of sepsis, cardiovascular events and reoperation compared with laparoscopic procedures. This study suggests that preference for laparoscopic procedures is another strategy that may reduce pulmonary complication rates, at least in the setting of bariatric surgery (19) .
Although controversial, a systematic review of 141 trials including 9,559 patients reported a reduction in risk with the use of epidural or spinal anesthesia compared to general anesthesia (20) . The negative effect of general anesthesia on lung mechanics, gas exchange and respiratory center drive is well known. The persistence of these effects in the postoperative period can make extubation difficult or else precipitate the appearance of respiratory failure (21) . Moreover, depending on the type of surgery performed, the risk of the appearance of complications during the postoperative period may increase. This risk is due to the severe alteration these procedures exert on lung mechanics (22).
In conclusion, our patients with COPD had higher rates of both pulmonary and cardiac complications. Hence, many of the criteria used to evaluate surgical risk are extrapolated from the results in patients with COPD. Our preliminary data in conjunction with the lack of controlled trials make one wonder if routine bronchodilator use triggered solely by spirometric abnormalities is warranted. The complication rate is higher for surgical sites closer to the diaphragm, such as the upper abdomen. Because it is "minimally invasive", laparoscopic surgery might have advantages in patients with underlying lung disease.
